Literature DB >> 32060532

The Risk of Sexually Transmitted Infections Following First-Episode Schizophrenia Among Adolescents and Young Adults: A Cohort Study of 220 545 Subjects.

Chih-Sung Liang1,2, Ya-Mei Bai3,4, Ju-Wei Hsu3,4, Kai-Lin Huang3,4, Nai-Ying Ko5, Hsuan-Te Chu1, Ta-Chuan Yeh6, Shih-Jen Tsai3,4, Tzeng-Ji Chen7,8, Mu-Hong Chen3,4.   

Abstract

Young people are disproportionately affected by sexually transmitted infections (STIs). The risk of STIs in young people following first-episode schizophrenia is unknown. This study using Taiwan's National Health Insurance Research Database enrolled 44 109 adolescents and young adults with first-episode schizophrenia and 176 436 age- and sex-matched controls without schizophrenia from 2001 through 2009 and followed to the end of 2011. New-onset STIs were identified. Survival analysis was performed. Cox regression analysis was used to examine the effects of comorbid substance use disorder (SUD), schizophrenia medications, and schizophrenia severity. The E value for causality of evidence was calculated. We found that young people had a higher risk of STIs following first-episode schizophrenia compared with controls without schizophrenia (hazard ratio [HR] = 2.35, 95% CI = 2.08-2.64); these STIs included human immunodeficiency virus (HIV) (3.70, 2.60-5.28) and syphilis (5.35, 3.96-7.23). They also showed a disproportionate distribution of STIs, with an increased proportion of syphilis (20.4% vs 8.2%) and HIV (9.1% vs 6.0%). When presenting with SUD, the risks of HIV (11.00, 7.02-17.25) and syphilis (9.11, 6.16-13.47) were further increased. The severe schizophrenia group had an extremely high risk of syphilis (41.26, 27.69-61.47) and HIV (7.50, 3.85-14.62). Schizophrenia medications may provide beneficial effects against contracting STIs (0.77, 0.68-0.89). We concluded that following first-episode schizophrenia, young patients are at higher risk of STIs, particularly HIV and syphilis. The risk further increased when subjects presented with SUD or severe schizophrenia. Importantly, antipsychotic treatment may lower the risk of STIs.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  adolescent; first-episode schizophrenia; human immunodeficiency virus; sexually transmitted infection; syphilis; young adults

Mesh:

Substances:

Year:  2020        PMID: 32060532      PMCID: PMC7344918          DOI: 10.1093/schbul/sbz126

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  40 in total

1.  Emerging homosexual conduct during hospitalization among chronic schizophrenia patients.

Authors:  Y M Bai; Y Huang; C C Lin; J Y Chen
Journal:  Acta Psychiatr Scand       Date:  2000-11       Impact factor: 6.392

2.  Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.

Authors:  Chia-Fen Tsai; Mu-Hong Chen; Yen-Po Wang; Chi-Jen Chu; Yi-Hsiang Huang; Han-Chieh Lin; Ming-Chih Hou; Fa-Yauh Lee; Tung-Ping Su; Ching-Liang Lu
Journal:  Gastroenterology       Date:  2016-09-14       Impact factor: 22.682

3.  Sex education and rehabilitation with schizophrenic male outpatients.

Authors:  D Lukoff; D Gioia-Hasick; G Sullivan; J S Golden; K H Nuechterlein
Journal:  Schizophr Bull       Date:  1986       Impact factor: 9.306

Review 4.  Syphilis and HIV infection: an update.

Authors:  Nicola M Zetola; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2007-03-14       Impact factor: 9.079

5.  Sexual activity and risk of HIV infection among patients with schizophrenia.

Authors:  F Cournos; J R Guido; S Coomaraswamy; H Meyer-Bahlburg; R Sugden; E Horwath
Journal:  Am J Psychiatry       Date:  1994-02       Impact factor: 18.112

Review 6.  HIV/AIDS risks as a consequence of schizophrenia.

Authors:  I I Gottesman; C S Groome
Journal:  Schizophr Bull       Date:  1997       Impact factor: 9.306

Review 7.  Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.

Authors:  Emma E McGinty; Julia Baller; Susan T Azrin; Denise Juliano-Bult; Gail L Daumit
Journal:  Schizophr Bull       Date:  2015-07-28       Impact factor: 9.306

Review 8.  Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.

Authors:  Catherine Lindsey Satterwhite; Elizabeth Torrone; Elissa Meites; Eileen F Dunne; Reena Mahajan; M Cheryl Bañez Ocfemia; John Su; Fujie Xu; Hillard Weinstock
Journal:  Sex Transm Dis       Date:  2013-03       Impact factor: 2.830

9.  A systematic comparison of recurrent event models for application to composite endpoints.

Authors:  Ann-Kathrin Ozga; Meinhard Kieser; Geraldine Rauch
Journal:  BMC Med Res Methodol       Date:  2018-01-04       Impact factor: 4.615

Review 10.  Schizophrenia.

Authors:  Michael J Owen; Akira Sawa; Preben B Mortensen
Journal:  Lancet       Date:  2016-01-15       Impact factor: 79.321

View more
  3 in total

1.  Diagnostic progression to schizophrenia in 35,255 patients with obsessive-compulsive disorder: a longitudinal follow-up study.

Authors:  Mu-Hong Chen; Shih-Jen Tsai; Chih-Sung Liang; Chih-Ming Cheng; Tung-Ping Su; Tzeng-Ji Chen; Ya-Mei Bai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-03-24       Impact factor: 5.270

2.  Risks of Major Mental Disorders and Irritable Bowel Syndrome among the Offspring of Parents with Irritable Bowel Syndrome: A Nationwide Study.

Authors:  Ta-Chuan Yeh; Ya-Mei Bai; Shih-Jen Tsai; Tzeng-Ji Chen; Chih-Sung Liang; Mu-Hong Chen
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

3.  Risks of major mental disorders after parental death in children, adolescents, and young adults and the role of premorbid mental comorbidities: a population-based cohort study.

Authors:  Chih-Sung Liang; Mu-Hong Chen; Dian-Jeng Li; Shih-Jen Tsai; Tzeng-Ji Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-07-23       Impact factor: 4.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.